One-year financing exceeded 8 billion | Medical device field finally ushered in the outbreak?

Medical Network News March 20

When it comes to health care investment in the healthcare industry, what segmentation areas do you think of the first time?

Is it mobile internet? Innovative medicine? Or precision medicine?

In the above three subdivided areas, there have been no shortage of investors and Entrepreneurship The eyeballs. But there is such a subdivision area that has long been regarded as China's largest short board in the medical and health industry. It has also been considered by some investors that there is no suitable investment target in the country. This subdivision area is called medical instruments.

However, with the promotion of national policies, the popularity of medical devices in the domestic venture capital industry has increased significantly over the past two years. A set of data are used to illustrate the situation: According to statistics from the Securities Times and Venture Capitalists, according to public statistics, in 2017, The field of medical devices was disclosed. There were 67 financing cases with clear financing subjects, and the open financing amount was as high as 8 billion yuan. The amount of financing in a single case exceeded 100 million yuan.

The flow of feng shui turns. Is it really necessary for the medical device segment to break out?

In the case of financing disclosed last year, according to statistics, there were 33 medical equipment involved, of which the company had won the industry championship with a financing amount of RMB 3.33 billion. The second area was diagnosis, with a total of 15 cases; Gene sequencing, Gene detection There are seven cases. The last is the medical consumables category, only one. In the open investor information, there appeared Softbank China, Honghui Capital, Lilly Asia Fund, Gaotejia Investment, Zhenge Fund, Jingwei China, etc. Well-known body figure.

This heat continues into this year. Recently, Beden Medical announced the completion of a new round of billion-dollar financing, but the specific amount and the investor did not disclose it.

Prior to this, Beideng Medical won the A round of financing of 65 million yuan in November 2016. The investors include Zhongwei Fund, Fuhai Dongfang and Puhua Capital; in June 2015, Beideng Medical obtained share investment and Shenzhen Pengrui Investment Group. Co., Ltd. 30 million yuan Pre-A round of financing; In addition, it also received Angeline Capital's angel investment.

Founded in 2012, Baden Medical is a medical device B2B platform, which is mainly purchased by upstream medical device manufacturers and serves downstream medical device distributors and some private medical institutions. Founder Ding Haibo and several partners have previously Served in Alibaba, B2B Department of Global Sources, team members also from Mindray, Olympus and other professional medical equipment production suppliers.

It is understood that Beden Medical has docked 500 upstream medical device manufacturers, nearly 15,000 small and medium-sized distributors, 20,000 SKUs on the platform, and the platform has established two online and offline sales systems.

From the perspective of investment, medical devices have developed rapidly in overseas markets. According to the latest report from the US CB Insights, the amount of investment and financing transactions of private medical device companies in the world has increased significantly in 2016. A total of 479 investments have been completed and the investment has been near. 4.8 billion US dollars. In the global medical device investment and financing transactions, the United States accounted for 77% of the trading share, followed by Israel and the United Kingdom.

In terms of market size, the gap between China and the United States is still relatively clear. In 2015, the global market for medical devices was 390.3 billion U.S. dollars, the U.S. market was the largest, reaching 208.4 billion U.S. dollars, while the Chinese market was 370 billion U.S. dollars. , accounting for 1/6 of the global market, the United States only 6.03% growth rate of medical devices, while China's growth rate is about 17%.

However, there are also insiders pointed out that the global medical device accounted for medicine With 42% of the total market size, and China's medical devices account for 9.16% of the total pharmaceutical market, China's medical device industry still has a lot of room for development. Therefore, China has ushered in the golden years of medical devices.

Overall, the global consumption ratio of pharmaceuticals and medical devices is approximately 1:0.7, while developed countries such as Europe, the United States, Japan have reached 1:1.02, and the global medical device market has occupied 42% of the total size of the international pharmaceutical market, and has expanded. The trend is that the market has great prospects, rapid growth, obvious pain points in the industry, etc. China has no listed company in the field of device circulation.

Industry bluntly, China's medical equipment enterprise There are still some obvious problems. First, the low-price bidding strategy of domestic brands. The lack of strategic positioning, lower than the standard high-end products, and proxy Businesses also squeeze profits. This has also caused these companies to be at a disadvantage in competition. They have not had enough profits to continue R&D, lack of financial support, and upgrading and replacement are also facing technical and financial pressures. Market brands have invested insufficiently.

Second, a single technology breakthrough is difficult to form a platform advantage. Lack of long-term technology portfolio, dilute customer development costs, afraid to invest in training and development of customers.

Third, there is a gap in technical details in the process of simple imitation. The shape is similar to that of God, and with the localization of the production of imported products, domestic companies should really grasp the technology and product development ideas. Key raw materials, high-precision processing equipment and technology can be clearly grasped Shorten the gap.

Yang Cuihua, founding partner of Sanjiang Capital, believes that the reason why China now has a large gap with developed countries in Europe and America is because China's medical market is highly regulated and all foreign projects have problems in China. Current medical standards in China In spite of the need for some of the most sophisticated medical instruments And high-end technology has come to industrialize, but at the same time, China needs more low-cost, adequate medical equipment. 'China has a large number of hospitals in second and third-tier cities. If the coverage of domestic medical insurance is not large enough, we must first address some basic issues. Problem. In my opinion, some technologies are also possible. The products are relatively innovative in application. The prospect of being able to import imported medical devices is promising.

Chuang Feng Capital Partners Zhang Ke believes that there is a clear growth cycle in the field of equipment, which is different from the Internet's unlimited money-burning model. The equipment field will only burn money in the early stages of research and development, and the cycle is only about three years. Can not be completely imitation, and often there will be some innovation in imitation. For fund investment, the burning cycle of three to five years is very healthy, overall the risk in this area is not. '

It is not difficult to find that, as a whole, investing in medical innovation technology will be the future trend. In China's future market, domestic import substitution is the general trend, and the country’s policy is also tilting toward domestically produced devices. Overseas, cost-effective Chinese manufacturing will be as early as possible for international companies. The brand is challenging on a global scale. It will truly break the bottleneck in the development of medical devices worldwide, deepen clinical research, new materials, new technology and other basic disciplines, and combine new emerging disciplines such as artificial intelligence to accelerate technological iterations. Perhaps, China Medical The golden decade in the field of equipment is slowly unfolding.